Company intelligence / Profile preview

Strathspey Crown

Newport Beach, California, United States

Ownership: Private
Employees: ~27
Development stage: Other

Overview

Strathspey Crown is a specialized healthcare growth equity firm with investments and subsidiaries in lifestyle medicine, medical devices, pharmaceuticals, and related biotechnology companies. It is notably involved in investments and acquisitions of companies developing neurotoxins for both cosmetic and therapeutic use (e.g., Evolus, AEON Biopharma). Detailed clinical results are not directly attributed to Strathspey Crown but to its portfolio companies.

Modalities: BiologicSmall molecule
Industry: Investors

Partnerships

Daewoong Pharmaceutical (for neurotoxin licensing and development)

Beyond the preview

Go deeper on Strathspey Crown.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Strathspey Crown.

Explore the full profile